Search results
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients - British...
Nature· 3 days agoTregs trafficking is controlled by CXCR4. In Renal Cell Carcinoma (RCC), the effect of the new CXCR4 antagonist, R54, was explored in ...
Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 23 hours agoInvestors' focus will likely be on Iovance's (IOVA) progress with its ongoing commercial launch for...
Fighting Cancer: A Basic Guide To Checkpoint Inhibitors
Forbes· 1 day agoThis article is part of an ongoing series on novel cancer advances, including immunotherapies such...
Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short
Zacks via Yahoo Finance· 6 days agoEXEL targets to file an investigational new drug application for XB010, XB628...
New York State Common Retirement Fund Sells 5,141 Shares of Iovance Biotherapeutics, Inc....
ETF DAILY NEWS· 4 days agoNew York State Common Retirement Fund trimmed its holdings in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 0.5% during the 4th quarter, according to the company in ...
Short Interest in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Rises By 5.6%
ETF DAILY NEWS· 5 days agoIovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 48,980,000 shares ...
HC Wainwright Reaffirms Buy Rating for Exelixis (NASDAQ:EXEL)
ETF DAILY NEWS· 1 day agoHC Wainwright reaffirmed their buy rating on shares of Exelixis (NASDAQ:EXEL – Free Report) in a research report sent to investors on Friday, Benzinga reports. Several other equities analysts ...
Headlands Technologies LLC Has $32,000 Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL)
ETF DAILY NEWS· 4 days agoHeadlands Technologies LLC cut its stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 70.6% in the 4th quarter, Holdings Channel.com reports. The fund owned 1,341 shares of the biotechnology ...
Retirement Systems of Alabama Sells 8,056 Shares of Exelixis, Inc. (NASDAQ:EXEL)
ETF DAILY NEWS· 4 days agoRetirement Systems of Alabama cut its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 2.0% during the fourth quarter, according to the company in its most recent disclosure ...
Sutent Dosage: Form, Strengths, How to Take, and More
Healthline· 6 days agoSutent is a prescription drug used to treat certain types of cancer. Learn about the drug's dosages, form, strengths, how to take it, and more.